Consensus is $1.88B. Cost of sales for 2025 is expected to be approximately $0.8B-$0.9B, lowered from $1.2B. The company continues to expect its full-year tax expense to be negligible. Capital expenditures for 2025 are expected to be approximately $0.3B.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA: